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Abstract
Several chronic respiratory diseases exhibit hyperactive immune responses in the lung: abundant inflammatory mediators;
infiltrating neutrophils, macrophages, lymphocytes and other immune cells; and increased level of proteases. Such diseases
include cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and severe/neutrophilic asthma. Paradoxically,
patients with these diseases are also susceptible to detrimental bacterial infection and colonization. In this paper, we seek to
explain how a positive feedback mechanism via IL-8 could lead to desensitization of epithelial cells to pathogen recognition
thus perpetuating bacterial colonization and chronic disease states in the lung. Such insight was obtained from
mathematical modeling of the IRAK/TRAF6 signaling module, and is consistent with existing clinical evidence. The potential
implications for targeted treatment regimes for these persistent respiratory diseases are explored.
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Introduction
Human epithelial cells are the first line of defense against
external pathogens and particulates. The innate immune responses
mediated by these cells are important for host defense against
bacteria and viruses [1,2]. A number of TIR-domain containing
receptors play important roles in the initial pathogen recognition
by Toll-Like Receptors (TLRs) or the triggering of adaptive
responses via cytokine receptors (e.g. receptors for IL-1 or IL-18).
Signaling through the downstream MyD88-IRAK1/4-TRAF6
cascade has been shown to be essential for biological events
mediated by Toll-Like Receptors against some bacteria (TLR2,
TLR5), single strand RNA (TLR7) or DNA (TLR9) viruses. These
signals will be referred as extrinsic stimuli in this paper.
The IRAK4/IRAK1 complex is recruited to activated receptors
by stimuli such as cytokines, bacteria, or viruses through the
interaction of IRAK4 with MyD88 and additional partners. It is
phosphorylated at multiple residues to produce activated IRAK1
proteins. The activated IRAK1 then forms a complex with
TRAF6 to activate downstream MAPK and NF-kappaB cascades
and subsequently induce the production of chemokines (for
example IL-8), cytokines and antibacterial peptides. The level of
activated IRAK1 proteins is controlled by the rapid ubiquitin-
targeted degradation of phosphorylated IRAK1. This key
signaling component in innate immunity will be referred as the
core IRAK/TRAF6 module in this paper (Figure 1).
IL-8, a major chemoattractant for neutrophil recruitment, is
produced by epithelial cells upon IRAK/TRAF6 activation. A
positive feedback loop from IL-8 signals to NF-kappaB though the
IRAK module has been reported [3], and neutrophil elastase
produced by recruited neutrophils could potentially induce epithelial
IL-8 production through IRAK signaling [4]. For example, recent
work from Hartl et al suggested that proteases, such as neutrophil
elastases, could cleave IL-8 receptor CXCR1 into fragments to
activate TLR2 and its downstream IRAK signaling in epithelial cells
[5]. In this paper, we refer to these mechanisms as ‘‘intrinsic stimuli’’.
Thefocusofourstudywastoexaminehow an IL-8mediatedpositive
feedback loop through the IRAK/TRAF6 module, induced by
intrinsic or extrinsic signals, could impact the host’s innate immune
response in the context of localized inter-cellular events between
epithelial cells and neutrophils.
A detailed schematic model of the TLR and IL-1 signaling
cascades is available and the robustness of the IRAK signaling has
been discussed previously [6]. This earlier model by Kitano et al
focused principally on cytokine signaling feedback, systematic
leukocyte development, and benevolent bacteria fauna. In our
study, we focused more exclusively on epithelial cells and the
effects of positive chemokine feedback on the innate immune
response of these cells. We have explored how the fragilities in
epithelial innate immune responses can lead to chronic disease
states in lung epithelium with desensitized microbial recognition
and bacterial colonization in the presence of neutrophils and
inflammatory mediators.
Results
Intrigued by the reported IL-8 positive feedback loop to IRAK
signaling by Monna, et al [3], we were interested in modeling the
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5332impact of this finding on the dynamics and different steady states
of the innate immune responses mediated by the IRAK/TRAF6
module. A model for the module was constructed in JDesigner [7]
(graphic representation shown in Figure 1) in SBML (Systems
Biology Markup Language). The model consists mainly of the core
IRAK(IRAK1 and IRAK4)/TRAF6 regulatory module, with
various inputs to activate IRAK4 from either the extrinsic stimulus
(Figure 1, pink arrow with a circular arrowhead, a kinetic
approximation of multiple signaling steps from ligand-receptor
activation, MyD88 binding, to IRAK4 recruitment) or the intrinsic
IL-8 feedback (Figure 1, dark yellow arrow, an approximation of
activation steps of IL-8 induced neutrophil recruitment, neutrophil
elastase production and subsequent feedback to the recruitment of
IRAK4 by activated receptors). Activated IRAK4 then binds to
IRAK1 to form a complex (IRAK1/IRAK4). Since the multi-step
processes of phosphorylation of IRAK1 are mediated by the kinase
activities in this complex, the reactions were modeled as Michaelis-
Menten reactions using ATP as the only substrate. The IRAK1/
TRAF6 complex-formation step is closely coupled with rapid
ubiquitin-mediated IRAK1 degradation [8] that regulates the level
of downstream output. The activated IRAK1/TRAF6 then
induces IL-8 production (Figure 1, red arrow, a highly
approximated estimate from the multiple-step activation through
the MAPK and IKK-NF-kappaB cascades, transcription, tran-
script stability, translation and post-translational processing).
Depending on the initial cellular states at the time of
stimulation, this signaling module would respond to IRAK4
activation by external stimuli (cytokines, bacteria, or viruses) with
different outcomes in time series analysis. Given a pulse-like
stimulus from baseline (at 0), the cells can either induce a response
in IL-8 level that returns to the initial state of 0 (Figure 2A, green
line, ‘‘resolved’’), or reach a steady state of constitutive IL-8
expression even after the original stimuli dissipates (Figure 2A,
blue line, ‘‘self-reinforced’’). In subsequent discussions, we will
refer to the initial cellular states that give the ‘‘resolved’’ responses
as State 0, and those that give the ‘‘self-reinforced’’ responses will
be referred as State 1.
The parameters that impact the state switches between
‘‘resolved’’ (State 0) and ‘‘self-reinforced’’ (State 1) of final IL-8
levels are examined through both sensitivity analyses (data not
shown) and parameter scans (Figure 2B–D) using Matlab
Simbiology or Systems Biology Workbench. From all the
Figure 1. A schematic view of the IRAK/TRAF6 signaling module. Recruited by activated TIR containing receptors (for stimuli like cytokines,
bacteria, or viruses, pink arrow with a closed-circle arrowhead) through interaction with MyD88, the IRAK4/IRAK1 complex undergoes multi-step
phosphorylation to produce activated IRAK1 proteins. Activated IRAK1 proteins complex with TRAF6 to induce production of IL8 (red arrow), which
forms a positively feedback loop to activate IRAK4 (dark yellow arrow). The activated IRAK1 protein is controlled by rapid degradation.
doi:10.1371/journal.pone.0005332.g001
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PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5332Figure 2. IRAK/TRAF6 response to external stimulus is dependent on the initial condition. A. Given an external stimulus (dashed red line,
introduced at time 0 and decay over time), the signaling through IRAK/TRAF6 can either ‘‘resolve’’ (green line, representing an response of IL-8 that
returns to 0) or become ‘‘self-reinforced’’ (blue line, representing a constitutive IL-8 level that positively feeds back to the IRAK/TRAF6 module).I fa
new external stimulus is introduced (dashed red line, introduced at time 50,000) to the system in a ‘‘resolved’’ state, a robust response of IL-8 is
produced. If the system is in a ‘‘self-reinforced’’ state, the response to the new stimulus is ‘‘desensitized’’ as a much diminished response (blue line).
The system states associated with ‘‘resolved’’ responses are defined as ‘‘State 0’’ (green in all panels); and those states associated with ‘‘self-
reinforced’’ response are called ‘‘State 1’’ (blue). B–D: Parameter scans for the sensitive parameters whose change can introduce a switch between
‘‘State 0’’ and ‘‘State 1’’. B. Rate of IL-8 mediated activation of IRAK4 (dark yellow arrow in Figure 1); C. IRAK1/TRAF6 induced production of IL-8 (red
arrow in Figure 1); D. Disassociation rate of the IRAK1/TRAF6 complex. B(i)–D(i): Matlab time responses for various parameter values in ‘‘State 0’’
(green lines) or ‘‘State 1’’ (blue lines). B(ii)–D(ii): Parameter ranges predicted by SBW that would exhibit state changes in the final IL-8 values.
doi:10.1371/journal.pone.0005332.g002
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the rate of IL-8 mediated activation of IRAK4 (Figure 2B, dark
yellow arrow in Figure 1), the rate of IRAK1/TRAF6 induced IL-
8 production mediated by the processes of downstream MAPK
and/or NF-kappaB signaling (Figure 2C, red arrow in Figure 1),
and the dissociation rate for the IRAK1/TRAF6 complex
(Figure 2D). At sensitive ranges (Figure 2Bii, 2Cii, 2Dii), small
changes of these parameters in State 0 (green lines, Figure 2Bi–
2Di) can push the system to fall into the constitutive IL-8
producing State 1 (blue lines, Figure 2Bi–2Di), or vice versa.
There are many possible intracellular or extracellular factors
that could impact these parameters to create a heightened innate
immune response: viral/bacterial infections [9], genetic variation
in proteases/anti-protease or receptor activities [10,11], other
cytokines that raise innate immune baseline responses, or genetic
variation or intracellular modulation of IL-8 production [12–14].
Cellular states of heightened innate immunity during the time of
stimulation can condition cells preferentially to State 1 leading to
self-enforcing IL-8 production and release, high recruitment of
neutrophils, and a high level of neutrophil elastase production.
An interesting result arose when we introduced a spike of
external stimulus as an input for the IRAK/TRAF6 module at
State 1 (Figure 2A, time=50000). Because the host’s constitutively
active IL-8 could saturate the IRAK/TRAF6 signaling, the host
epithelial cells could then become desensitized in responding
external stimuli (Figure 2A, blue line, time . 50000). Even though
the cells have fully active IRAK1/TRAF6 signaling, the host
epithelial cells may, paradoxically, be effectively inert to some
pathogens. This would occur particularly in situations where the
IRAK/TRAF6 signaling is the only way the host can detect such
pathogens and mount an effective innate immune response against
them. This state of heightened cellular activation with desensitized
defense predicted by this model may seem counter-intuitive at first;
however, there is abundant evidence in the literature that these
states exist in many inflammatory epithelial diseases, particularly
in the lung.
To identify the epithelial diseases with constitutive levels of IL-8,
we utilized the MedScan text mining capability available in
Ariadne PathwayStudio. Using IL-8 constitutive expression as the
Pubmed search criteria, the top 10,000 resulting abstracts were
mined for diseases that shared relationships with IL-8 (Figure 3). A
number of refractory respiratory diseases were identified (blue
box). Interestingly, most of these diseases that display a signature
of IL-8 constitutive expression also exhibit a phenotype of
susceptibility to infection by bacteria: cystic fibrosis (CF, caused
by genetic mutations in CFTR-cystic fibrosis transmembrane
conductance regulator), chronic obstructive pulmonary disease
(COPD), neutrophilic asthma [15], and other lung diseases.
Cystic fibrosis patients have constitutive high levels of IL-8 in
their blood and sputum, and their lungs are obstructed with dead
neutrophils and colonized by S. aureus or P. aeruginosa [16].
Additionally, the rate of IL-8 production in response to stimulation
in naı ¨ve CF cells is much faster than in healthy cells [17,18].
Supporting our prediction (Figure 2A), CF nasal polyps exhibited
constitutively higher basal, level of IL-8 and higher activity of NF-
kappaB. Incubation with P. aeruginosa or IL-1beta resulted in less
increase of IL-8 secretion by CF cells (1.4 fold) than by non-CF
cells (6.3 fold, reaching the basal IL-8 level in CF cells). This is
consistent with the observation that activity of NF-kappaB
(contributing to the rate of IRAK/TRAF6 induced IL-8 in our
Figure 3. Diseases associated with IL-8 constitutive expression. A number of chronic respiratory diseases, such as cystic fibrosis, COPD and
asthma (in the blue box) are identified to be associated with constitutively high level of IL-8 through text-mining PubMed abstracts in MedScan.
These chronic respiratory diseases also exhibit a phenotype of susceptibility to bacteria infection. IL-8 constitutive expression is also associated with a
number of cancers, and additional inflammatory diseases.
doi:10.1371/journal.pone.0005332.g003
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than in non-CF cells [19]. Recently, functional CFTR is reported
to be a negative regulator of NF-kappaB mediated signaling [20].
COPD
IL-8 induced neutrophil enrichment is associated with chronic
obstructive pulmonary disease (COPD). Higher rates of produc-
tion of IL-8 were observed in cells from smokers with COPD, and
persistent inflammation is associated with COPD long after smoke
cessation. [14,21,22]. COPD patients are also prone to exacerba-
tions associated with bacteria infection and colonization [23]. The
spectrum of the pathogens tends to overlap with those of severe
asthma and CF [24].
Neutrophilic Asthma
A higher number of severe asthma patients, compared with mild
asthma patients, exhibit a disease phenotype of persistent high IL-
8 level, higher neutrophil counts, and higher bacteria endotoxins
in their induced sputum [15,25]. Such an asthma subtype can be
defined as neutrophilic asthma. IL-8 level has been identified in
several studies as being closely associated with low lung function in
asthmatic patients [26].
In summary, these disparate chronic respiratory diseases have a
common theme in their disease manifestation: increased IL-8
levels, increase neutrophils, and ineffective host defense to certain
pathogens. These observations suggest this model is operative in
these diseases.
Discussion
To mount a defense against pathogens or respond to other
damaging or noxious stimuli, the hosts’ innate immune systems
need to achieve allostases; in other words, maintain sufficient
innate response yet not become hyper-responsive or desensitized
to microbial recognition. For the species to survive these
pathological or physiological insults, there is substantial evolution-
ary and population diversity for these sensitive parameters in and
around the IRAK/TRAF6 module. Our model predicts that the
qualitative diversity in these parameters affect the host’s
responsiveness towards environmental pathogens [11,27,28]. At
the extreme, these normal population variances could also
contribute to propensity for the development of chronic
inflammatory and infectious diseases.
Genetic variation in signaling intermediates, frequency or
severity of bacterial/viral infections, exposure to tobacco smoke,
aging, or the presence or absence of alternative cytokine profiles
are all possible susceptibility factors that can contribute to the
changes in the identified sensitive parameters in the IRAK/
TRAF6 signaling module. In cystic fibrosis, COPD and neutro-
philic asthma, chronic inflammation and damage to the mucosal
epithelial barrier could predispose patients to bacteria infection
(Figure 4). The first wave of bacteria infection could trigger an
epithelial immune response resulting in constitutive levels of IL-8
(State 1). High levels of IL-8 would increase recruitment of
neutrophils which would secrete high levels of neutrophil
proteases. Such hyperactive immune responses would lead to
higher level of proteases in the epithelial environment. Higher
level of proteases will then break down pulmonary structures as,
for example, in COPD. IL-8 can also promote angiogenesis [29],
leading to additional pathological changes in the lung.
Paradoxically, our model also predicts that constitutively
expressed IL-8 could desensitize the TLR-IRAK-TRAF6 signal-
ing. Innate immune responses to Staphylococcus aureus signal though
IRAK-dependent TLR2 [30,31], and Pseudomonas aeruginosa is
recognized through IRAK-dependent TLR5 signaling [32]. In
susceptible patients (State 1) at the time of infection, the host may
not be able to recognize these bacteria through the respective
TLRs because the downstream IRAK/TRAF6 module has been
overwhelmed by intrinsic signals. When desensitized recognition is
coupled with defective clearance, the pathogen can then effectively
evades host immunity to colonize the host. Interestingly, the
chronic respiratory diseases with constitutive IL-8 levels are prone
to colonization by a similar spectrum of bacteria (including S.
aureus and P. aeruginosa) as are IRAK4-deficient children with the
non-responsive IRAK/TRAF6 signaling [31]. Once trapped in
this state, our model predicts that cells may be slow or unable to
return to normal because these bacteria are also capable of directly
activating the IRAK/TRAF6 module thus triggering vicious
cycles of infection, ineffective bacteria clearance, and chronic
inflammation.
Our exploration of the IRAK/TRAF6 signaling module has
been focused primarily on specific cell types, specifically epithelial
cells and recruited neutrophils. However, there is obviously
substantially more complexity in the extracellular signals and cell
types that affect the epithelial environment, including monocytes,
dendritic cells, mast cells, macrophages, and various lymphocytes
[1,33]. A potential weakness of the model is that it does not
capture antibacterial peptide responses which are also regulated by
the IRAK/TRAF6 module. Moreover, this model also does not
address the potential defects in neutrophil activity in a protease-
rich environment, for example, through the cleavage of chemokine
receptor CXCR1 [5]. As additional signaling modules and cellular
responses are defined, future disease models will need to
incorporate them to better understand the fine-tuning of the
signaling pathways of host immune response. Many of these
chronic diseases have periods of exacerbation followed by
resolution, suggesting that other feedback mechanisms in the
system are important. Such counter-regulatory responses are
typically robust enough to successfully return the system to the
normal state. Occasionally, the detrimental combinatorial effects
of these internal states and external factors in the host could
override these checks and balances, resulting in chronic inflam-
mation and bacterial colonization. In epithelial diseases where
neutrophils play a major role, the IL-8 feedback and the IRAK/
TRAF6 signaling module appears to be a critical component of
this process.
The underlying mechanisms of the aforementioned diseases
suggest that their treatment should be distinguished from diseases
with similar symptoms but with different mechanisms. In chronic
respiratory diseases characterized by both chronic neutrophilic
inflammation and bacteria infection, this model suggests that
epithelial cells may be trapped in a self-reinforcing positive
feedback loop. Endogenous counter-regulatory pathways could be
insufficient to resolve pro-inflammatory signaling. There would
therefore be a need for external therapeutic interventions that
break such a cycle. For example, Hartl et al [5] showed that
inhalation of alpha1-antitripsin, a neutrophil elastase inhibitor,
could restore the killing of P. aeruginosa in cystic fibrosis patients.
Such a result can be explained by this model. Blocking neutrophil
elastase would reduce the feedback from IL-8 to the IRAK/
TRAF6 module by reducing the protease cleaved CXCR1
fragments, which signal to epithelial TLR2 to activate the
IRAK/TRAF6 module. This model also helps to explain why
impaired bacterial killing only impacts the clearance of certain
bacteria in cystic fibrosis. In addition to topical treatments, our
model also predicts that well-dosed systemic administration of
drugs that reduce chemokine production (and are often considered
to be at risk of causing increased infection in normal systems),
Modeling Respiratory Diseases
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disease states. Given the broad range of inflammatory diseases
potentially associated with this mechanism, these results have
important therapeutic implications in the treatment of chronic
respiratory diseases including cystic fibrosis, COPD and neutro-
philic asthma.
Materials and Methods
Model Construction
The IRAK/TRAF6 model was constructed in SBML (Model
S1) using JDesigner2.0 in the SBW (Systems Biology Workbench
www.sbml.org) package. The initial concentrations of the model
species were mostly estimated. The initial parameters were either
estimated or constrained using literature or experimental data
[34]. The best parameterized part is the core IRAK1/ IRAK4
enzyme reactions in which the kcat is defined in s
21 and the Km
defined in mM
21. The state presented in the attached model is
prone to the switch between State 0 and State 1.
Time Series Analysis, Sensitivity Analysis and Parameter
Scan
Time series analyses of the model were performed in either
SBW JDesigner or Matlab Simbiology. Sensitivities of parameters
in regards to IL-8 level (t=15,000) in the systems were identified
using the MatLab SimBiology module with the Sundial solver.
Parameter scans on all the individual parameters were performed
using the Jarnac simulation service in the SBW package. Those
sensitive parameters that exhibited a change from/to 0 in IL-8
levels in the scanned ranges were then simulated close to the
switching range in the Matlab Simbiology parameter scan. In
addition to the parameters identified in Figure 2B–2D, changes in
the rate of IL-8 degradation can also switch the attached model
between State 0 and State 1.
Text Mining
Text mining of diseases associated with IL-8 constitutive levels
or expression were performed using MedScan 1.0 (available from
Ariadne 5.0) looking for either co-occurance or Ariadne-defined
relationships. Only those diseases with at least 2 relevant
references associated with IL-8 were selected. The published
network was generated based on the first 10000 PubMed abstracts
downloaded with the search terms ‘‘Interleukin-8’’ AND (‘‘con-
stitutive’’ OR ‘‘level’’ OR ‘‘expression’’) on September 18
th, 2008.
Supporting Information
Model S1 The IRAK/TRAF6 model in the SBML format.
Quantitative (internal and external) enzyme kinetics data and
literature knowledge on structure of the signaling pathways were
Figure 4. Potential mechanisms of hyper-inflammation and microbial colonization in chronic respiratory diseases. Genetic
predispositions and environmental insults lead to chronic modification in pulmonary mucosal epithelial barriers in cystic fibrosis, COPD and
neutrophilic asthma patients. Initial microbial infection could lead to a switch into State 1 with hyperactive epithelial innate immune responses
resulting in constitutive IL-8 level, high neutrophil count, high protease levels and additional changes in pulmonary structure. Due to the intrinsic IL-8
positive feedback, bacteria recognition through TLR-IRAK-TRAF6 signaling could become desensitized. These bacteria could evade innate immunity
and colonize the lung when the host’s anti-microbial activities are compromised.
doi:10.1371/journal.pone.0005332.g004
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[34] (Hekmad-Nejad, manuscript in preparation; Zhang et al,
proceeding I04 at ICSB 2007). The core IRAK enzymatic
reactions were the best characterized part of the model, with
other parts estimated based on constraints from the literature. The
parameter sets were rested close to the state switch between State 0
and State 1.
Found at: doi:10.1371/journal.pone.0005332.s001 (0.01 MB ZIP)
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